About Eli Miloslavsky, MD

Dr. Miloslavsky specializes in the diagnosis and treatment of vasculitis and other systemic diseases such as inflammatory myopathy and sarcoidosis among others.  He is the Co-Director of the MGH Vasculitis and Glomerulonephritis center. His research has focused on outcomes and treatment of ANCA-Associated Vasculitis and glucocorticoid toxicity.  

Dr. Miloslavsky also has a strong interest in medical education.  He currently teaches at MGH and Harvard Medical School where he holds several leadership roles. Within medical education his research has focused on simulation, consultative medicine, science education and peer teaching. 

Dr. Miloslavsky graduated from the Icahn School of Medicine at Mount Sinai and completed his internal medicine residency and rheumatology fellowship at MGH.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Rheumatology
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 4B
Boston, MA 02114
Phone: 617-726-7938

Medical Education

  • MD, Mount Sinai School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Internal Medicine, American Board of Internal Medicine
  • Rheumatology, American Board of Internal Medicine

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Publications

  • Wallace ZS, Miloslavsky EM. Management of ANCA associated vasculitis. British Medical Journal 2020 Mar 18;368:m421

    Miloslavsky EM, Niles JL, Wallace ZS et al. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Seminars in Arthritis and Rheumatism 2018 Oct;48(2):288-292.

    Miloslavsky EM, Naden, RP, Bijlsma JW, et al. Development of a Glucocorticoid Toxicity Index (GTI) Using Multi-Criteria Decision Analysis. Annals of the Rheumatic Diseases 2017 Mar;76(3):543-546.

    Miloslavsky EM, Specks U, Merkel PA et al. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatology. 2013 Sep;65(9):2441-9

    Other publications can be found at:https://pubmed.ncbi.nlm.nih.gov/?term=miloslavsky%20e&sort=date

Reviews: Comments and Ratings

4.9out of 5(106 Ratings, 48 Comments)

May 2025

Dr. Eli is great, He listens and addresses any concerns that you may during the visit.


May 2025

Top notch


April 2025

Exceptional--experienced and thoughtful, supportive and caring, explains details clearly and concisely, impressive training of excellent resident.


April 2025

Dr. Miloslavsky is amazing. He's very knowledgeable. He's very compassionate. He's an excellent listener and he makes time for his patients even when he doesn't have time.


April 2025

He is a major asset to the hospital. Excellent bedside manner, caring, knows his craft, polite, patient and understanding.


April 2025

He took his time and gave me all the attention that I needed, and he treated me like a person not a number cared about what I was going through most definitely would recommend him to anyone


April 2025

This was the best doctors visit that I have ever had. Amazing doctor who reviewed my history prior to the appt. Took the time to ask many questions and went over everything as through as possible so that he could give his opinions. He really seemed to care about providing the best choices/opinions he could. Extremely happy with how the appt went ... Read More


March 2025

Excellent provider


March 2025

Dr. Eli is thorough and easy to talk to. Very knowledgeable and listens to my concerns!


March 2025

The entire staff was fabulous. Thank you.

View More
Ratings and Comments Powered by NRC Health